Stockscreener 앱 받기
292.48
0.58%
1.69
시장 영업 전:
293.00
0.52
+0.18%
전일 마감가:
$290.79
열려 있는:
$291.17
하루 거래량:
1.52M
Relative Volume:
0.67
시가총액:
$65.86B
수익:
$189.25B
순이익/손실:
$5.36B
주가수익비율:
12.45
EPS:
23.5
순현금흐름:
$5.34B
1주 성능:
+5.81%
1개월 성능:
-14.15%
6개월 성능:
-24.16%
1년 성능:
-44.38%
1일 변동 폭
$289.72
$293.40
1주일 범위
$273.71
$299.45
52주 변동 폭
$273.71
$567.26
엘리번스 헬스 Stock (ELV) Company Profile
명칭
Elevance Health Inc
전화
(800) 331-1476
주소
220 VIRGINIA AVENUE, INDIANAPOLIS
ELV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
292.48 | 65.48B | 189.25B | 5.36B | 5.34B | 23.50 |
|
UNH
Unitedhealth Group Inc
|
261.57 | 228.94B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
65.51 | 82.29B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
280.47 | 73.95B | 260.93B | 5.02B | 3.94B | 18.32 |
|
HUM
Humana Inc
|
274.94 | 32.07B | 117.76B | 1.21B | 2.39B | 9.95 |
엘리번스 헬스 Stock (ELV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-21 | 다운그레이드 | Argus | Buy → Hold |
| 2025-07-18 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | 업그레이드 | Argus | Hold → Buy |
| 2025-01-22 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-07-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-06-24 | 개시 | Morgan Stanley | Overweight |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-06 | 개시 | Barclays | Overweight |
| 2023-07-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-03-28 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
모두보기
엘리번스 헬스 주식(ELV)의 최신 뉴스
Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy’ Rating With $342 PT - sg.finance.yahoo.com
Barrow, Hanley, Mewhinney & Strauss Reduces Stake in Elevance Health Inc by 54.26% - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elevance Health, Inc. (ELV) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
When a Healthcare Giant Gets Sick: Elevance Health’s 20% YTD Decline - InsuranceNewsNet
When a Healthcare Giant Gets Sick: Elevance Health's 20% YTD Decline - MSN
Is Elevance Health Inc. a turnaround storyDouble in 10 Days Stock Ideas - thegnnews.com
Bronstein, Gewirtz & Grossman, LLC Encourages Elevance Health, Inc. (ELV) Investors to Inquire about Securities Investigation - ACCESS Newswire
Baird Reduces PT on Elevance Health (ELV) Stock, Maintains Neutral - MSN
Mizuho Securities Maintains Buy Rating on Elevance Health with $342 Price Target - AInvest
Elevance Health (ELV) Nosedives 12% on Disappointing Q2 - MSN
UBS Affirms Elevance Health’s (ELV) ‘Buy’ Rating on Earning Stability and Growth Prospects - Insider Monkey
Baird Lowers Elevance Health Price Target to $297, Maintains Neutral Rating. - AInvest
Iowa House panel dismisses ethics complaint over lobbying on PBM bill - The Des Moines Register
Meta Platforms and Elevance Health have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
Bear of the Day: Elevance Health (ELV) - The Globe and Mail
Bear Of The Day: Elevance Health (ELV) - Barchart.com
Is it the right time to buy Elevance Health Inc. stockFree Stock Market Trend Analysis - Jammu Links News
When is Elevance Health Inc. stock expected to show significant growthDynamic investment opportunities - Jammu Links News
How strong is Elevance Health Inc. company’s balance sheetCapitalize on market opportunities with confidence - Jammu Links News
Is Elevance Health Inc. stock overvalued or undervaluedFree Risk Assessment Services - Jammu Links News
Should I hold or sell Elevance Health Inc. stock in 2025Proven strategies for superior portfolio growth - Jammu Links News
What are Elevance Health Inc. company’s key revenue driversAchieve consistent double-digit growth - Jammu Links News
Why is Elevance Health Inc. stock attracting strong analyst attentionInvest confidently with real-time data - Jammu Links News
What are analysts’ price targets for Elevance Health Inc. in the next 12 monthsUnlock daily market insights for better decisions - Jammu Links News
Insider Activity at Elevance Health: A Tale of Confidence and Cautious Diversification - AInvest
Elevance Health Insiders Sell US$6.7m Of Stock, Possibly Signalling Caution - Yahoo Finance
Trapped Investors in Elevance Health Inc. Await Breakout SignalMarket Entry and Exit Point Tips From Traders - metal.it
Elevance Health stock hits 52-week low at $274.33 - Investing.com Australia
Elevance Health stock hits 52-week low at $274.33 By Investing.com - Investing.com India
Elevance Health shares fall 2.10% intraday after UnitedHealth Group's CFO replacement announcement. - AInvest
UnitedHealth replaces CFO Rex in another management shake-up - Reuters
Peter Lynch's Top Health Care Stocks Based on Validea: Elevance Health and UFP Technologies - AInvest
Why Elevance Health Inc. stock attracts strong analyst attentionSwing Setup With Technical Confirmation Explained - metal.it
Positive Sentiment Still Eludes Elevance Health, Inc. (NYSE:ELV) Following 25% Share Price Slump - simplywall.st
Does Elevance Health (NYSE:ELV) Have A Healthy Balance Sheet? - Yahoo Finance
Elevance Health Board Appoints Steve Collis As Director - citybiz
Momentum Screeners Rank Elevance Health Inc. in Top 5 TodayRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Elevance Health, Inc. (ELV) Downgrades 2025 Earnings Amid Rising Medical Costs - MSN
Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance Excellence - The Globe and Mail
Medicare Advantage in 2025: Enrollment Update and Key Trends - KFF
Elevance Health (ELV) Receives Buy Rating from UBS with Optimistic EPS Forecast - GuruFocus
Elevance Health, Inc: A Deeply Undervalued Long-Term OpportunityF.A.S.T. GraphsCommentaries - Advisor Perspectives
Is Elevance Health Inc. a growth stock or a value stockGet daily updates on promising stocks - jammulinksnews.com
What makes Elevance Health Inc. stock price move sharplyFree Stock Review For Consistent Profits - jammulinksnews.com
How many analysts rate Elevance Health Inc. as a “Buy”Unlock real-time trading signals for gains - jammulinksnews.com
What is the dividend policy of Elevance Health Inc. stockMarket-crushing profits - Jammu Links News
엘리번스 헬스 (ELV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
자본화:
|
볼륨(24시간):